Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
VRTXVertex Pharmaceuticals Inc Live data
$542.92▼ -4.98 (-0.9%)as of Nov 11, 2026, 6:18 PM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$412.27$568.67
1-Month Range
Month up 11.9%
$485.22$558.88
Daily Price Range
Day down -0.9%
$535.46$545.32
Volume
vs 1M avg
3538801M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$137.5B
Short % of Float—
Employees—
Sales$12,001M
Shares Outstanding253,991,224
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.vrtx.com
Vertex Pharmaceuticals Inc — is a public issuer in the Vantage universe..
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
60
Growth
72
Quality
88
Sentiment
87
Insider Sent.
—
Piotroski F
5
Altman Z
13.9
Consensus rating unavailable — no analyst coverage on file for VRTX.
Price targets unavailable — no 12-month targets on file for VRTX.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on VRTX, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:18 PM UTC